Syringes containing 5 g of an 18.75% oral paste formulation of fenbendazole as a ready to administer oral anthelmintic and anti-protozoal for domestic rabbits. 1 g contains 0.187 g active ingredient fenbendazole.
A broad spectrum anthelmintic as an aid in the control of Encephalitozoon cuniculi and intestinal worms in domestic rabbits.
Dosage and administration
Panacur Rabbit should be administered orally by squeezing the paste from the syringe into the side of the mouth.
Administer 1 syringe graduation per 2.5 kg bodyweight (20 mg/kg fenbendazole) daily for 9 consecutive days.
Routine dosing of rabbits is recommended 2-4 times yearly.
Dosing should also be considered during periods of higher risk, such as when the rabbit is acquired, prior to mating and when mixing with other rabbits.
For single treatment course only.
Contra-indications, warnings, etc
Direct contact with the skin should be kept to a minimum. Wash hands after use.
Assess bodyweight as accurately as possible before calculating the dosage.
For animal treatment only. Keep out of reach and sight of children.
Do not store above 25°C. Dispose of empty packaging and any remaining product in the household refuse.
This veterinary medicine is marketed in accordance with the Small Animal Exemption Scheme.
5 g syringes and packs of 10 x 5 g syringes.
Encephalitozoon cuniculi is an intracellular protozoan parasite which can cause a range of clinical signs including hind limb paresis, head tilt, collapse, urinary incontinence, cataract formation and lens-induced uveitis and death. Transmission is primarily via ingestion of spores shed in the urine contaminating food and/or water.
A 2006 UK study showed a seroprevalence of 52% in domestic rabbits indicating the widespread nature of the parasite.
Panacur Rabbit is an aid in the control of E. cuniculi and it is recommended that additional preventative measures are taken such as ensuring that food and water are placed appropriately to prevent urine contamination.
E. cuniculi has zoonotic potential and infection has been reported in immunosuppressed people.
Marketing authorisation number
Customers interested in this product may also be interested in